SpringWorks Therapeutics (SWTX) News Today $35.59 +0.81 (+2.33%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Barclays PLC Purchases 58,645 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Barclays PLC lifted its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 60.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 155,676 shares of the company's stock aftDecember 21 at 4:09 AM | marketbeat.comAnalyzing SpringWorks Therapeutics (NASDAQ:SWTX) and Titan Pharmaceuticals (NASDAQ:TTNP)December 18 at 2:08 AM | americanbankingnews.comTarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 PicksDecember 15, 2024 | seekingalpha.comLord Abbett & CO. LLC Has $34.27 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Lord Abbett & CO. LLC decreased its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 48.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,069,738 shares of the company's stock after sellingDecember 15, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 12.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 99,737 shares of the company's sDecember 14, 2024 | marketbeat.comMain Management ETF Advisors LLC Makes New $746,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Main Management ETF Advisors LLC acquired a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 23,280 shares of the companyDecember 8, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Increases Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Charles Schwab Investment Management Inc. increased its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 13.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 602,227 shares of thDecember 7, 2024 | marketbeat.comBadreddin Edris Sells 20,000 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) StockDecember 6, 2024 | insidertrades.comSoros Fund Management LLC Buys 174,321 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Soros Fund Management LLC increased its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 45.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 559,321 shares of the company's stock after acquiring an addDecember 6, 2024 | marketbeat.comErste Asset Management GmbH Makes New $397,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Erste Asset Management GmbH acquired a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 12,300 shares of the company's stock, valued at approxDecember 5, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Purchases 162,137 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)The Manufacturers Life Insurance Company raised its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 131.4% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 285,555 shares of the company's stock after purchasing an additionalDecember 4, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by HighVista Strategies LLCHighVista Strategies LLC lowered its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 29.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,852 shares oDecember 3, 2024 | marketbeat.comWalleye Capital LLC Grows Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Walleye Capital LLC raised its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 2,439.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 286,093 shares of the company's stocDecember 1, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Rating of "Buy" from AnalystsSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) has earned an average recommendation of "Buy" from the six brokerages that are presently covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price target amoDecember 1, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Acquired by Fmr LLCFmr LLC grew its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 0.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,140,946 shares of the company's stock after buyDecember 1, 2024 | marketbeat.comIntech Investment Management LLC Acquires New Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Intech Investment Management LLC bought a new stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 21,084 shares of the company's stock, valued at apprDecember 1, 2024 | marketbeat.comDynamic Technology Lab Private Ltd Makes New $439,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Dynamic Technology Lab Private Ltd bought a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 13,717 shares of the company's stock, valued at approximatNovember 30, 2024 | marketbeat.comAlly Bridge Group NY LLC Makes New Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Ally Bridge Group NY LLC purchased a new stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 227,700 shares of the company's stock, vNovember 28, 2024 | marketbeat.comSpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx ConferenceNovember 26, 2024 | globenewswire.comMassachusetts Financial Services Co. MA Has $20.61 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Massachusetts Financial Services Co. MA raised its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 20.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 643,192 shares of the company's stock after buyiNovember 26, 2024 | marketbeat.comAlpha DNA Investment Management LLC Purchases Shares of 12,843 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Alpha DNA Investment Management LLC purchased a new stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 12,843 shares of the company's stock, vaNovember 25, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Eagle Asset Management Inc.Eagle Asset Management Inc. lowered its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 16.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 273,479 shares of the coNovember 24, 2024 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Trading 8.1% Higher - Should You Buy?SpringWorks Therapeutics (NASDAQ:SWTX) Shares Up 8.1% - Should You Buy?November 22, 2024 | marketbeat.comSpringWorks Therapeutics Inc. (SWTX): Among the NASDAQ Stocks with Biggest Upside Potential According to AnalystsNovember 22, 2024 | msn.comJ.P. Morgan Sticks to Their Buy Rating for Springworks Therapeutics (SWTX)November 21, 2024 | markets.businessinsider.comSpringWorks Therapeutics initiated with an Outperform at Evercore ISINovember 21, 2024 | markets.businessinsider.comSpringworks Therapeutics (SWTX) Gets a Buy from Evercore ISINovember 21, 2024 | markets.businessinsider.comEvercore ISI Group Initiates Coverage of SpringWorks Therapeutics (SWTX) with Outperform RecommendationNovember 21, 2024 | msn.comSpringWorks Therapeutics (NASDAQ:SWTX) Now Covered by Evercore ISIEvercore ISI began coverage on shares of SpringWorks Therapeutics in a research note on Wednesday. They issued an "outperform" rating and a $60.00 price objective on the stock.November 20, 2024 | marketbeat.comVictory Capital Management Inc. Has $20.17 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Victory Capital Management Inc. lifted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 19.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 629,387 shares of the company's stock aftNovember 19, 2024 | marketbeat.comHC Wainwright Has Pessimistic View of SWTX FY2024 EarningsSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) - Research analysts at HC Wainwright cut their FY2024 earnings estimates for shares of SpringWorks Therapeutics in a note issued to investors on Tuesday, November 12th. HC Wainwright analyst R. Burns now expects that the company will earnNovember 15, 2024 | marketbeat.comWedbush Equities Analysts Lower Earnings Estimates for SWTXSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) - Investment analysts at Wedbush reduced their FY2024 earnings estimates for SpringWorks Therapeutics in a research report issued to clients and investors on Tuesday, November 12th. Wedbush analyst D. Nierengarten now expects that the comNovember 15, 2024 | marketbeat.comLos Angeles Capital Management LLC Acquires 33,255 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Los Angeles Capital Management LLC lifted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 238.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 47,212 shares of the company'November 14, 2024 | marketbeat.comBuy Rating Reaffirmed for Springworks Therapeutics Amid Promising Outlook for Ogsiveo and MirdametinibNovember 13, 2024 | markets.businessinsider.comBarclays Sticks to Its Buy Rating for Springworks Therapeutics (SWTX)November 13, 2024 | markets.businessinsider.comSpringWorks Therapeutics (NASDAQ:SWTX) Announces Earnings Results, Beats Estimates By $0.04 EPSSpringWorks Therapeutics (NASDAQ:SWTX - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.72) earnings per share for the quarter, topping the consensus estimate of ($0.76) by $0.04. The company had revenue of $49.10 million for the quarter, compared to analyst estimates of $53.28 million. During the same quarter last year, the company earned ($1.27) EPS. The firm's revenue for the quarter was up 4810.0% on a year-over-year basis.November 13, 2024 | marketbeat.comSpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 13, 2024 | finanznachrichten.deSpringWorks Therapeutics Q3 2024 Results OverviewNovember 13, 2024 | markets.businessinsider.comPrincipal Financial Group Inc. Acquires 464,903 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Principal Financial Group Inc. grew its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 102.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 918,445 shares of the company's stock afteNovember 13, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (SWTX) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comHC Wainwright Issues Pessimistic Forecast for SpringWorks Therapeutics (NASDAQ:SWTX) Stock PriceHC Wainwright lowered their price objective on shares of SpringWorks Therapeutics from $76.00 to $74.00 and set a "buy" rating for the company in a research report on Tuesday.November 12, 2024 | marketbeat.comSpringWorks Therapeutics to Participate in the Jefferies London Healthcare ConferenceNovember 12, 2024 | globenewswire.comSpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 12, 2024 | globenewswire.comEarnings To Watch: SpringWorks Therapeutics Inc (SWTX) Reports Q3 2024 ResultNovember 11, 2024 | finance.yahoo.comSpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual MeetingNovember 11, 2024 | globenewswire.comSpringWorks Therapeutics Announces Publication of the Pivotal Phase 2b ReNeu Trial Evaluating Mirdametinib in Adults and Children with NF1-PN in the Journal of Clinical OncologyNovember 11, 2024 | globenewswire.comFiera Capital Corp Sells 39,338 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Fiera Capital Corp trimmed its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 3.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,257,964 shares of the company's stockNovember 9, 2024 | marketbeat.comSpringWorks Therapeutics Announces Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors to be Presented at the Connective Tissue Oncology Society (CTOS) 2024 Annual MeetingNovember 7, 2024 | globenewswire.comSpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation ConferenceNovember 5, 2024 | finance.yahoo.comSpringWorks Therapeutics (SWTX) Scheduled to Post Earnings on TuesdaySpringWorks Therapeutics (NASDAQ:SWTX) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=638250)November 5, 2024 | marketbeat.com Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. SWTX Media Mentions By Week SWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SWTX News Sentiment▼0.940.61▲Average Medical News Sentiment SWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SWTX Articles This Week▼34▲SWTX Articles Average Week Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Qiagen News Today Intra-Cellular Therapies News Today Roivant Sciences News Today Ascendis Pharma A/S News Today Revolution Medicines News Today Lantheus News Today Nuvalent News Today Legend Biotech News Today Blueprint Medicines News Today Elanco Animal Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SWTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SWTX Stock Alerts